These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37109335)

  • 1. Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients.
    Ureche C; Dodi G; Covic A; Nedelcu A; Volovăț SR; Sascău RA; Stătescu C; Covic A
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
    Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; Clark AL; Cosmi F; Cuthbert J; Diez J; Edelmann F; Hazebroek M; Heymans S; Mariottoni B; Pellicori P; Petutschnigg J; Pieske B; Staessen JA; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F
    Eur J Heart Fail; 2022 Sep; 24(9):1559-1568. PubMed ID: 35703355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased procollagen type I C-terminal peptide levels indicate diastolic dysfunction in end-stage renal disease patients undergoing maintenance dialysis therapy.
    Su CT; Liu YW; Lin JW; Chen SI; Yang CS; Chen JH; Hung KY; Tsai WC; Huang JW
    J Am Soc Echocardiogr; 2012 Aug; 25(8):895-901. PubMed ID: 22658561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients.
    Ureche C; Dodi G; Șerban AM; Covic AS; Voroneanu L; Hogaș S; Sascău RA; Stătescu C; Covic A
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of Parameters of Transmitral Blood Flow and Markers of Myocardial Fibrosis in Patients with Myocardial Infarction].
    Osokina AV; Karetnikova VN; Polikutina OM; Ivanova AV; Artemova TP; Ryzhenkova SN; Avramenko OE; Gruzdeva OV; Barbarash OL
    Kardiologiia; 2020 Jul; 60(6):994. PubMed ID: 32720621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; Marwick TH
    Heart; 2013 Mar; 99(5):320-6. PubMed ID: 23343682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides.
    Ravassa S; Lupón J; López B; Codina P; Domingo M; Revuelta-López E; Moreno MU; San José G; Santiago-Vacas E; Cediel G; Roncal C; Díez J; Bayés-Genís A; González A
    JACC Heart Fail; 2023 Jan; 11(1):58-72. PubMed ID: 36599551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.
    Krishnasamy R; Hawley CM; Stanton T; Howden EJ; Beetham KS; Strand H; Leano R; Haluska BA; Coombes JS; Isbel NM
    Nephrology (Carlton); 2016 Feb; 21(2):108-15. PubMed ID: 26133896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of High Thoracic Sympathetic Nerve Block on Serum Collagen Biomarkers in Patients with Chronic Heart Failure.
    Sun G; Liu F; Qu R
    Cardiology; 2017; 136(2):102-107. PubMed ID: 27591776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
    Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
    J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
    Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
    Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.